Cargando…
Structure-based Ligand Design and the Promise Held for Antiprotozoan Drug Discovery
The development of the pharmaceutical industry, driven by progress in chemistry, biology, and technology, ranks as one of the most successful of human endeavors. However, serious health problems persist, among which are diseases caused by protozoan parasites, largely ignored in modern times. Advance...
Autor principal: | Hunter, William N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673241/ https://www.ncbi.nlm.nih.gov/pubmed/19103598 http://dx.doi.org/10.1074/jbc.R800072200 |
Ejemplares similares
-
Synthesis and In Vitro Antiprotozoan Evaluation of 4-/8-Aminoquinoline-based Lactams and Tetrazoles
por: Tukulula, Matshawandile, et al.
Publicado: (2020) -
Antiprotozoan and Antiviral Activities of Non-cytotoxic Truncated and Variant Analogues of Mussel Defensin
por: Roch, Philippe, et al.
Publicado: (2004) -
Role of serendipity in the discovery of classical antidepressant drugs: Applying operational criteria and patterns of discovery
por: López-Muñoz, Francisco, et al.
Publicado: (2022) -
Drug Discovery Strategies for SARS-CoV-2
por: Shyr, Zeenat A., et al.
Publicado: (2020) -
New‐Generation Ligand Design for the Gold‐Catalyzed Asymmetric Activation of Alkynes
por: Zuccarello, Giuseppe, et al.
Publicado: (2021)